Safety study of Folfox-HAIC in relieving bed restriction

Xiaoyun Zhao; Xingwei Sun; Jian Jing; Huimin Zhou; Yong Jin

doi:10.1016/j.jimed.2021.10.003

Safety study of Folfox-HAIC in relieving bed restriction

Journal of Interventional Medicine ◽

10.1016/j.jimed.2021.10.003 ◽

2021 ◽

Vol 4 (4) ◽

pp. 203-207

Author(s):

Xiaoyun Zhao ◽

Xingwei Sun ◽

Jian Jing ◽

Huimin Zhou ◽

Yong Jin

Keyword(s):

Safety Study

Download Full-text

Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammandex: a dose-finding and safety study

Yearbook of Anesthesiology and Pain Management ◽

10.1016/s1073-5437(08)70037-8 ◽

2007 ◽

Vol 2007 ◽

pp. 34-35

Author(s):

H.T. Lee

Keyword(s):

Neuromuscular Block ◽

Dose Finding ◽

Binding Agent ◽

Safety Study

Download Full-text

Low cardiovascular event rate in post-menopausal women with increased cardiovascular risk; Two year blinded summary from the ongoing Libigel (testosterone gel) cardiovascular safety study

PsycEXTRA Dataset ◽

10.1037/e512622013-014 ◽

2011 ◽

Author(s):

Michael C. Snabes ◽

Joanne Zborowski

Keyword(s):

Cardiovascular Risk ◽

Cardiovascular Event ◽

Event Rate ◽

Cardiovascular Safety ◽

Safety Study ◽

Menopausal Women ◽

Testosterone Gel ◽

Post Menopausal

Download Full-text

Safety Study of Intraarticular Injection of Interleukin 1 Receptor Antagonist in Patients With Painful Knee Osteoarthritis: A Multicenter Study

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70352-3 ◽

2006 ◽

Vol 2006 ◽

pp. 56-57

Author(s):

M.H. Pillinger

Keyword(s):

Knee Osteoarthritis ◽

Receptor Antagonist ◽

Multicenter Study ◽

Interleukin 1 ◽

Intraarticular Injection ◽

Safety Study ◽

Interleukin 1 Receptor Antagonist ◽

Painful Knee

Download Full-text

Safety Study of Culinary-Medicinal Royal Sun Agaricus, Agaricus brasiliensis S. Wasser et al. KA21 (Higher Basidiomycetes) Assessed by Prokaryotic as well as Eukaryotic Systems

International Journal of Medicinal Mushrooms ◽

10.1615/intjmedmushr.v14.i2.20 ◽

2012 ◽

Vol 14 (2) ◽

pp. 135-148 ◽

Cited By ~ 2

Author(s):

Masuro Motoi ◽

Naohito Ohno

Keyword(s):

Safety Study ◽

Agaricus Brasiliensis

Download Full-text

AN INTERNATIONAL, MULTICENTER, EFFICACY AND SAFETY STUDY OF A NOVEL IGNG IN INITIAL AND MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (CIDP)

10.26226/morressier.56e174d2d462b8028d88a729 ◽

2016 ◽

Author(s):

Rabye Ouaja

Keyword(s):

Maintenance Treatment ◽

Chronic Inflammatory Demyelinating Polyradiculoneuropathy ◽

Efficacy And Safety ◽

Safety Study ◽

International Multicenter

Download Full-text

Cognitive function in children and adolescents with ADHD receiving lisdexamfetamine dimesylate in a 2-year safety study

10.26226/morressier.5971be82d462b80290b52cf7 ◽

2017 ◽

Author(s):

Tobias Banaschewski

Keyword(s):

Cognitive Function ◽

Children And Adolescents ◽

Safety Study ◽

Lisdexamfetamine Dimesylate

Download Full-text

INTERIM RESULTS OF A POST-AUTHORIZATION SAFETY STUDY (PASS) ON THE LONG-TERM SAFETY OF FACILITATED SCIG 10% IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES IN THE US

10.26226/morressier.594a7d48d462b8028d8938ce ◽

2017 ◽

Author(s):

Kim Haines

Keyword(s):

Primary Immunodeficiency ◽

Primary Immunodeficiency Diseases ◽

Safety Study ◽

Immunodeficiency Diseases ◽

The Us

Download Full-text

EVOLVE-MS-1: a phase 3, open-label, long-term safety study of ALKS 8700 in relapsing-remitting multiple sclerosis

10.26226/morressier.59a3edabd462b8028d8952fe ◽

2017 ◽

Author(s):

Robert T. Naismith

Keyword(s):

Multiple Sclerosis ◽

Open Label ◽

Safety Study ◽

Phase 3 ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)

Case Medical Research ◽

10.31525/ct1-nct03867110 ◽

2019 ◽

Author(s):

Keyword(s):

Efficacy And Safety ◽

Safety Study ◽

Primary Hypercholesterolemia

Download Full-text

An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients

Case Medical Research ◽

10.31525/ct1-nct03897205 ◽

2019 ◽

Author(s):

Keyword(s):

Kidney Transplant ◽

Efficacy And Safety ◽

Safety Study ◽

Antibody Mediated Rejection ◽

Transplant Patients ◽

Kidney Transplant Patients

Download Full-text